As many cases of prostate cancer detected based on elevated PSA concentration will not be necessarily aggressive, there is a need to identify a subset of patients with indolent tumors for whom active surveillance is a primary option until signs of disease progression are present. The gene discussed is KLK3; the disease is prostate cancer.